NCT03246841View on ClinicalTrials.gov

Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.

NAActive, not recruitingINTERVENTIONAL
Enrollment

7,274

Participants

Timeline

Start Date

September 21, 2017

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Hereditary Breast and Ovarian CancerMutation
Interventions
OTHER

Genetic testing

A panel of 24 genes, chosen in advance by a steering committee, will be tested as the same time as the BRCA1/2 genes, at one of the usual BRCA1/2 analysis laboratories belonging to the same network and participating in the study.

Trial Locations (2)

Unknown

Gustave Roussy, Paris

Institut Curie - PIGE, Paris

All Listed Sponsors
collaborator

Institut Curie

OTHER

collaborator

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

UNICANCER

OTHER

NCT03246841 - Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes. | Biotech Hunter | Biotech Hunter